Drug Trial Radar · NCT05557409
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
Last checked: Nov 19, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
408
Actual
Start
Sep 6, 2022
Primary completion
Nov 21, 2024
Study completion Dec 21, 2024
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial was a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.
Conditions
- Agitation in Patients With Dementia of the Alzheimer's Type
- Alzheimer Disease
- Agitation
Interventions
AXS-05Drug
AXS-05 tablets, taken twice daily
PlaceboDrug
Placebo tablets, taken twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohen-Mansfield Agitation Inventory (CMAI)Time frame: Up to 5 weeks
Locations
55 sites in 2 countries. Site status is shown where the registry gives one.
Clinical Research Site
Peoria, Arizona
Clinical Research Site
Tempe, Arizona
Clinical Research Site
Tucson, Arizona
Clinical Research Site
Canoga Park, California
Clinical Research Site
Long Beach, California
Clinical Research Site
Los Alamitos, California
Clinical Research Site
Walnut Creek, California
Clinical Research Site
West Covina, California
Clinical Research Site
Bonita Springs, Florida
Clinical Research Site
Brandon, Florida
Clinical Research Site
Green Acres, Florida
Clinical Research Site
Hialeah, Florida
Clinical Research Site
Hollywood, Florida
Clinical Research Site
Kissimmee, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami Gardens, Florida
Clinical Research Site
Miami Lakes, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Pembroke Pines, Florida
Clinical Research Site
Tampa, Florida
Clinical Research Site
Tampa, Florida
Clinical Research Site
Augusta, Georgia
Clinical Research Site
College Park, Georgia
Clinical Research Site
Columbus, Georgia
Clinical Research Site
Wichita, Kansas
Clinical Research Site
Marrero, Louisiana
Clinical Research Site
Braintree, Massachusetts
Clinical Research Site
Flint, Michigan
Clinical Research Site
Rochester Hills, Michigan
Clinical Research Site
Troy, Michigan
Clinical Research Site
Chesterfield, Missouri
Clinical Research Site
Berlin, New Jersey
Clinical Research Site
Toms River, New Jersey
Clinical Research Site
Brooklyn, New York
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.